LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Emergent BioSolutions Inc

Emergent BioSolutions Inc

Closed

Sector Healthcare

7.46 -2.23

Buy Sell

Overview

Share price change

24h

Current

Min

7.45

Max

7.6

Key metrics
By Trading Economics
Sales	6.1M 277M
EPS	-0.77
Employees	1,600

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+57.27 upside

Market Stats
By TradingEconomics
Market Cap	1.1M 121M
Previous open	9.69
Previous close	7.46

News Sentiment

By Acuity

88%

12%

333 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

7.39 / 8.91 Support & Resistance

Emergent BioSolutions Inc Chart

Related News

12 Mar 2024, 15:10 UTC

Major Market Movers

Emergent BioSolutions Shares Drop on S&P Downgrade

Peer Comparison

Price change

Emergent BioSolutions Inc Forecast

Price Target

By TipRanks

57.27% upside

12 Months Forecast

Average 12 USD 57.27%

High 16 USD

Low 8 USD

Based on 2 Wall Street analysts offering 12 month price targets forEmergent BioSolutions Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Emergent BioSolutions Inc - Dist in the past 3 months.

Technical Score

By Trading Central

7.39 / 8.91Support & Resistance

All events are bearish.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

333 / 365 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Emergent BioSolutions Inc

Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.